AstraZeneca-Oxford Covid vaccine faces more questions after manufacturing error2 min read 26 Nov 2020, 05:25 PM IST
In a later statement, Oxford said a difference in manufacturing processes led to some participants being given a half dose instead of full one
Oxford said that when it was apparent that a lower dose was used, it was discussed with regulators, and agreement was reached to push ahead with two regimens
AstraZeneca Plc and the University of Oxford, among the front-runners in the quest to deliver a Covid-19 vaccine, face mounting questions about their trial results after acknowledging a manufacturing error.
Select your Category